Search

Search Constraints

You searched for: Author/Creator Graham, Danielle

Search Results

2. [P4–039]: PAN‐TAU ANTIBODY BIIB076 EXHIBITS PROMISING SAFETY AND BIOMARKER PROFILE IN CYNOMOLGUS MONKEY TOXICITY STUDY. (1st July 2017)

3. A pediatric quantitative systems pharmacology model of neurofilament trafficking in spinal muscular atrophy treated with the antisense oligonucleotide nusinersen. (5th December 2022)

5. An age‐dependent mathematical model of neurofilament trafficking in healthy conditions. (2nd March 2022)

7. Baseline biomarker (tau PET) characteristics from TANGO: A phase 2 trial of gosuranemab (BIIB092) in early Alzheimer's disease. (1st February 2022)

8. Baseline biomarker (tau PET) characteristics from TANGO: A phase 2 trial of gosuranemab (BIIB092) in early Alzheimer's disease. (December 2021)

9. Baseline characteristics from TANGO: Phase 2 study to evaluate gosuranemab (BIIB092) in patients with early Alzheimer's disease: Human: Improving clinical trial methodology. (7th December 2020)

10. Clinical value of CSF tau, p‐tau181, neurogranin and neurofilaments in familial frontotemporal lobar degeneration. (1st February 2022)